Morgan Stanley cuts Ionis price target to $104 from $110
Morgan Stanley cut its price target on Ionis Pharmaceuticals to $104.00 per share from $110.00, according to Benzinga ratings actions via TradingView News.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.